Development of local guidelines for prevention of respiratory syncytial viral infections
- 1 October 1999
- journal article
- research article
- Published by Wolters Kluwer Health in The Pediatric Infectious Disease Journal
- Vol. 18 (10) , 850-853
- https://doi.org/10.1097/00006454-199910000-00003
Abstract
No abstract availableThis publication has 18 references indexed in Scilit:
- Impact of Respiratory Syncytial Virus Immune Globulin in 1996-1997Archives of Pediatrics & Adolescent Medicine, 1999
- Annual Summary of Vital Statistics—1997Pediatrics, 1998
- Prevention of Respiratory Syncytial Virus Infections: Indications for the Use of Palivizumab and Update on the Use of RSV-IGIVPediatrics, 1998
- Palivizumab, a Humanized Respiratory Syncytial Virus Monoclonal Antibody, Reduces Hospitalization From Respiratory Syncytial Virus Infection in High-risk InfantsPediatrics, 1998
- International variation in the management of infants hospitalized with respiratory syncytial virusEuropean Journal of Pediatrics, 1998
- Respiratory Syncytial Virus Immune Globulin Intravenous: Indications for UsePediatrics, 1997
- Reduction of Respiratory Syncytial Virus Hospitalization Among Premature Infants and Infants With Bronchopulmonary Dysplasia Using Respiratory Syncytial Virus Immune Globulin ProphylaxisPediatrics, 1997
- Prophylactic Administration of Respiratory Syncytial Virus Immune Globulin to High-Risk Infants and Young ChildrenNew England Journal of Medicine, 1993
- Respiratory Syncytial Virus and InfluenzaAmerican Journal of Diseases of Children, 1976